<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00588016</url>
  </required_header>
  <id_info>
    <org_study_id>06-009651</org_study_id>
    <nct_id>NCT00588016</nct_id>
  </id_info>
  <brief_title>Concentration of Itraconazole Solution in Nasal Secretions</brief_title>
  <official_title>Concentration of Itraconazole Solution in Nasal Secretions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to determine the concentration of itraconazole&#xD;
      irrigation in nasal mucous specimens via collection and High-performance liquid&#xD;
      chromatography (HPLC) assay.&#xD;
&#xD;
      Eight (8) patients with chronic rhinosinusitis (CRS) and two (2) healthy controls will be&#xD;
      enrolled in the initial evaluation. After an initial control nasal specimen, followed by&#xD;
      seven days of twice daily topical itraconazole irrigation, nasal specimens will be collected&#xD;
      at varying time intervals and the concentrations measured.&#xD;
&#xD;
      The primary endpoint is development of a reliable collection and assay technique with&#xD;
      concentration curves over time of topically administered itraconazole. A secondary endpoint&#xD;
      is to determine if the concentrations measured achieve a mean inhibitory concentration&#xD;
      (MIC90) to commonly cultured fungal species in the nose.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot study for the purpose of gathering concentration data on a commonly used&#xD;
      topical antifungal solution of itraconazole. CRS patients that meet the defined inclusion&#xD;
      criteria will begin topical itraconazole antifungal irrigations on Day 1. This will consist&#xD;
      of Itraconazole in Sterile Water 100 mg/1000 ml, irrigating each nostril with 20 ml of&#xD;
      solution twice daily, with a bulb syringe as directed. The patient will return on Day 7 for&#xD;
      repeat examination and nasal secretion collection. Two patients will be randomly selected to&#xD;
      have blood drawn at the completion of day 7 testing to determine the concentration of&#xD;
      itraconazole in the blood.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Concentration of Itraconazole in nasal secretions at 7 days</measure>
    <time_frame>7 days after initiation of study</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Sinusitis</condition>
  <arm_group>
    <arm_group_label>Itraconazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical application of Itraconazole in Sterile Water 100 mg/1000 ml, irrigating each nostril with 20 ml of solution twice daily for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Itraconazole</intervention_name>
    <description>Topical application of Itraconazole in Sterile Water 100 mg/1000 ml, irrigating each nostril with 20 ml of solution twice daily for 7 days.</description>
    <arm_group_label>Itraconazole</arm_group_label>
    <other_name>Sporanox</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        General:&#xD;
&#xD;
          -  Greater than or equal to eighteen years of age.&#xD;
&#xD;
          -  Patient must be willing to be available and comply with all scheduled procedures as&#xD;
             defined in the protocol.&#xD;
&#xD;
          -  Patients that have been felt to be candidates for topical itraconazole therapy and&#xD;
             would have been started on the therapy regardless of study inclusion&#xD;
&#xD;
        Medical:&#xD;
&#xD;
          -  CRS defined by American Academy of Otolaryngology - Head and Neck Surgery (AAO HNS)&#xD;
             guidelines&#xD;
&#xD;
        Controls:&#xD;
&#xD;
          -  Do not meet CRS definitions. No acute sinusitis within past 4 weeks. No previous&#xD;
             surgery for rhinosinusitis. No history of allergic rhinitis or other rhinologic&#xD;
             disorders.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        General:&#xD;
&#xD;
          -  Previous use of a topical antifungal nasal irrigation within the past 2 weeks or a&#xD;
             systemic antifungal medication within the past 3 months.&#xD;
&#xD;
        Medical:&#xD;
&#xD;
          -  History of cystic fibrosis, immunodeficiency, immotile cilia syndrome, clinical or&#xD;
             radiographic suspicion for fungal mycetoma or invasive fungal sinusitis&#xD;
&#xD;
          -  Pregnancy - female patients of child bearing age will undergo a pregnancy test, if&#xD;
             positive they will be excluded&#xD;
&#xD;
          -  History of liver disease&#xD;
&#xD;
          -  History of congestive heart failure&#xD;
&#xD;
          -  Allergy or sensitivity to itraconazole, or other azole antifungals, or any other&#xD;
             ingredient in the preparation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hirohito Kita, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <study_first_submitted>December 26, 2007</study_first_submitted>
  <study_first_submitted_qc>January 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2008</study_first_posted>
  <last_update_submitted>April 12, 2015</last_update_submitted>
  <last_update_submitted_qc>April 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Hirohito Kita</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Itraconazole</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Itraconazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

